16.10.2022, 1156 Zeichen

Marinomed: Bernd Braunstein will support the Management Board of Austrian listed pharma company Marinomed as Corporate Counsel "in all legal matters, from corporate governance to partnership agreements and capital market law issues", as the company announces. Braunstein most recently worked at Wienerberger AG.
Marinomed Biotech: weekly performance: -4.49%

OMV: Austrian oil, gas and chemicals group OMV said a mechanical incident at its Schwechat refinery would have a negative impact on its third quarter result "as we expect payments from the business interruption insurance at a later point in time."
OMV: weekly performance: -3.53%

UBM: Roman Ehrentraut and Vladimír Pašek have been appointed to the Management Board of UBM Development Czechia as of 1 October where they will join Josef Wiedermann. Helmut Berghöfer is resigning from the Management Board at the end of this year but will remain available to the company. UBM-CEO Thomas G. Winkler: “With Vladimír and Roman, we have now optimally positioned UBM Czechia for the future.“
UBM: weekly performance: -2.12%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (10/10/2022)

Christian Drastil: Wiener Börse Plausch

Books from Friends #3: Die guten Kräfte (Walter Gröbchen)

Bildnachweis

Aktien auf dem Radar:Porr, Kapsch TrafficCom, AT&S, Semperit, RHI Magnesita, Amag, OMV, Lenzing, Strabag, Addiko Bank, FACC, Flughafen Wien, Frequentis, Gurktaler AG VZ, Heid AG, Reploid Group AG, Marinomed Biotech, Bajaj Mobility AG, voestalpine, BKS Bank Stamm, Austriacard Holdings AG, EuroTeleSites AG, CPI Europe AG, Österreichische Post, Telekom Austria, UBM, Fresenius Medical Care, Rheinmetall, SAP, Volkswagen Vz., BMW.

---